(Q37928134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

PROGRESS: Prevention of Recurrent Stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Hisatomi Arima

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

2 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

693-702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21896153%20AND%20SRC:MED&resulttype=core&format=json

Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack.

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American St

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Global burden of blood-pressure-related disease, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Blood pressure and cardiovascular disease in the Asia Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X

Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2011.00530.X